BRWA
RXII

B. Riley Wealth Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History

B. Riley Wealth Advisors’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,180
Closed -$31.1K – 2485
2014
Q2 		$31.1K Buy
+10,180
New +$31.1K 0.01% 1249

Other funds holding RXII

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

B. Riley Wealth Advisors's RXII Position: Q3 2014 in Review

B. Riley Wealth Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2014, closing a stake of 10,180 shares — an estimated $31.1K sold.

B. Riley Wealth Advisors first reported a position in RXII in Q2 2014 and held it in 1 quarter. The position peaked at $31.1K in Q2 2014. 85 funds tracked by Wall St. Rank hold RXII as of Q3 2014.

  • B. Riley Wealth Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2014 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 10,180 GALENA BIOPHARMA INC COM shares in Q3 2014, an estimated $31.1K.
  • B. Riley Wealth Advisors first reported a position in GALENA BIOPHARMA INC COM in Q2 2014 and held it in 1 quarter.
  • B. Riley Wealth Advisors's GALENA BIOPHARMA INC COM position peaked at $31.1K in Q2 2014.
  • 85 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2014.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.